Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Filip E Van den Bosch

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
Annals of the Rheumatic Diseases|May 30, 2020
Response to: 'Finding the right one' by ZanwarThomas Renson, Filip E Van den Bosch, Dirk Elewaut
Annals of the Rheumatic Diseases|June 30, 2021
Response to: 'Correspondence on 'Efficacy of a tight-control and treat-to-target strategy in axial spondyloarthritis: results of the open-label, pragmatic, cluster-randomised TICOSPA trial'' by Cai and PengAnna Molto, Désirée van der Heijde, Filip E Van den Bosch, et al.
Nature Reviews. Rheumatology|May 13, 2022
Improving the design of RCTs in non-radiographic axial spondyloarthritisWalter P Maksymowych, Robert G W Lambert, Liron Caplan, et al.
Annals of the Rheumatic Diseases|June 30, 2021
Unexpected impact of COVID-19 lockdown on spinal mobility and health perception in spondyloarthritisSophie De Mits, Ann-Sophie De Craemer, Liselotte Deroo, et al.
Annals of the Rheumatic Diseases|February 28, 2020
Immunoscintigraphy in axial spondyloarthritis: a new imaging modality for sacroiliac inflammationPhilippe Carron, Thomas Renson, Manouk de Hooge, et al.
Annals of the Rheumatic Diseases|December 10, 2017
Inequity in biological DMARD prescription for spondyloarthritis across the globe: results from the ASAS-COMOSPA studyElena Nikiphorou, Désirée van der Heijde, Sam Norton, et al.
Annals of the Rheumatic Diseases|July 14, 2018
Response to: 'Use of dual-energy CT to detect and depict bone marrow oedema in rheumatoid arthritis: is it ready to substitute MRI?' by Wu <i>et al</i>Lennart Jans, Isabelle De Kock, Nele Herregods, et al.
Annals of the Rheumatic Diseases|September 13, 2022
Recapture and retreatment rates with ixekizumab after withdrawal of therapy in patients with axial spondyloarthritis: results at week 104 from a randomised placebo-controlled withdrawal studyRobert B M Landewé, Denis Poddubnyy, Proton Rahman, et al.
Annals of the Rheumatic Diseases|October 29, 2020
Axial involvement in patients with early peripheral spondyloarthritis: a prospective MRI study of sacroiliac joints and spineThomas Renson, Philippe Carron, Ann-Sophie De Craemer, et al.
Dermatology and Therapy|August 17, 2024
Long-Term Safety of Risankizumab in Patients with Psoriatic Disease: A Comprehensive Analysis from Clinical TrialsKenneth B Gordon, Andrew Blauvelt, Hervé Bachelez, et al.
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Annals of the Rheumatic Diseases|May 30, 2020
Response to: 'Finding the right one' by ZanwarThomas Renson, Filip E Van den Bosch, Dirk Elewaut
Annals of the Rheumatic Diseases|June 30, 2021
Response to: 'Correspondence on 'Efficacy of a tight-control and treat-to-target strategy in axial spondyloarthritis: results of the open-label, pragmatic, cluster-randomised TICOSPA trial'' by Cai and PengAnna Molto, Désirée van der Heijde, Filip E Van den Bosch, et al.
Nature Reviews. Rheumatology|May 13, 2022
Improving the design of RCTs in non-radiographic axial spondyloarthritisWalter P Maksymowych, Robert G W Lambert, Liron Caplan, et al.
Annals of the Rheumatic Diseases|June 30, 2021
Unexpected impact of COVID-19 lockdown on spinal mobility and health perception in spondyloarthritisSophie De Mits, Ann-Sophie De Craemer, Liselotte Deroo, et al.
Annals of the Rheumatic Diseases|February 28, 2020
Immunoscintigraphy in axial spondyloarthritis: a new imaging modality for sacroiliac inflammationPhilippe Carron, Thomas Renson, Manouk de Hooge, et al.
Annals of the Rheumatic Diseases|December 10, 2017
Inequity in biological DMARD prescription for spondyloarthritis across the globe: results from the ASAS-COMOSPA studyElena Nikiphorou, Désirée van der Heijde, Sam Norton, et al.
Annals of the Rheumatic Diseases|July 14, 2018
Response to: 'Use of dual-energy CT to detect and depict bone marrow oedema in rheumatoid arthritis: is it ready to substitute MRI?' by Wu <i>et al</i>Lennart Jans, Isabelle De Kock, Nele Herregods, et al.
Annals of the Rheumatic Diseases|September 13, 2022
Recapture and retreatment rates with ixekizumab after withdrawal of therapy in patients with axial spondyloarthritis: results at week 104 from a randomised placebo-controlled withdrawal studyRobert B M Landewé, Denis Poddubnyy, Proton Rahman, et al.
Annals of the Rheumatic Diseases|October 29, 2020
Axial involvement in patients with early peripheral spondyloarthritis: a prospective MRI study of sacroiliac joints and spineThomas Renson, Philippe Carron, Ann-Sophie De Craemer, et al.
Dermatology and Therapy|August 17, 2024
Long-Term Safety of Risankizumab in Patients with Psoriatic Disease: A Comprehensive Analysis from Clinical TrialsKenneth B Gordon, Andrew Blauvelt, Hervé Bachelez, et al.
Pageof 3